retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric TRIUMPH-1 Trial Results: Retatrutide for

Glossary CKD Chronic kidney disease CVD Cardiovascular disease FDA Food and Drug Administration GLP-1 Glucagon-like peptide-1 GLP-1s Glucagon-like peptide-1 receptor agonists HF Heart failure MASH Metabolic dysfunction-associated steatohepatitis OA Osteoarthritis OSA Obstructive sleep apnea PAD Peripheral arterial disease SC Subcutaneous T2DM Type 2 diabetes mellitus U.S

Nojima Y, Takeda Y, Maeda Y, Bamba T, Fukusaki E, Itoh MN, et al

The pineal gland helps regulate melatonin, a hormone that supports sleep timing and circadian rhythm (the bodys 24-hour clock)

Nutrient Density Individuals with obesity are at increased risk of micronutrient deficiencies

Tesamorelin vs Other Peptide Therapies You may have come across other peptides like Semaglutide or AOD-9604 in your research